Atlas Trials

A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma

Clinical trial NCT01569919 · UNKNOWN

Trial details

NCT number
NCT01569919
Sponsor
Wales Cancer Trials Unit
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
MalignantPleuralMesothelioma
Start date
2012-12-01
Primary completion
2014-06-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.